首页> 美国卫生研究院文献>Data in Brief >Data on the concentrations of etoposide PSC833 BAPTA-AM and cycloheximide that do not compromise the vitality of mature mouse oocytes parthenogenetically activated and fertilized embryos
【2h】

Data on the concentrations of etoposide PSC833 BAPTA-AM and cycloheximide that do not compromise the vitality of mature mouse oocytes parthenogenetically activated and fertilized embryos

机译:依托泊苷PSC833BAPTA-AM和环己酰亚胺的浓度数据不会影响成熟小鼠卵母细胞孤雌激活和受精胚胎的活力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

These data document the vitality of mature mouse oocytes (Metaphase II (MII)) and early stage embryos (zygotes) following exposure to the genotoxic chemotherapeutic agent, etoposide, in combination with PSC833, a selective inhibitor of permeability glycoprotein. They also illustrate the vitality of parthenogenetically activated and fertilized embryos following incubation with the calcium chelator BAPTA-AM (1,2-Bis(2-aminophenoxy)ethane- N,N,N′,N′-tetraacetic acid tetrakis (acetoxymethyl ester)), cycloheximide (an antibiotic that is capable of inhibiting protein synthesis), and hydrogen peroxide (a potent reactive oxygen species). Finally, they present evidence that permeability glycoprotein is not represented in the proteome of mouse spermatozoa. Our interpretation and discussion of these data feature in the article “Identification of a key role for permeability glycoprotein in enhancing the cellular defense mechanisms of fertilized oocytes” (Martin et al., in press) .
机译:这些数据记录了暴露于遗传毒性化学治疗剂依托泊苷与通透性糖蛋白的选择性抑制剂PSC833组合后,成熟小鼠卵母细胞(中期II(MII))和早期胚胎(合子)的活力。他们还说明了钙螯合剂BAPTA-AM(1,2-双(2-氨基苯氧基)乙烷-N,N,N',N'-四乙酸四(乙酰氧基甲基酯))孵育后单性激活和受精胚胎的生命力。 ),环己酰亚胺(一种能够抑制蛋白质合成的抗生素)和过氧化氢(一种有效的活性氧)。最后,他们提供了证据,表明小鼠精子蛋白质组中不存在通透性糖蛋白。我们对这些数据的解释和讨论在“确定渗透性糖蛋白在增强受精卵细胞的细胞防御机制中的关键作用”一文中有所描述(Martin等人,印刷中)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号